Updates

Ref: 04/SE/LC/2026-27 Date: October 23, 2026 To, To, National Stock Exchange of India Limited BSE Limited (“BSE”) (“NSE”) Listing Department Listing Department Corporate Relationship Department Exchange Plaza, C-1 Block G, Bandra Kurla Phiroze Jeejeebhoy Towers, Complex Bandra (East), Mumbai – 400051 Dalal Street, Fort, Mumbai - 400 001 NSE Scrip Symbol: SMT BSE Scrip Code: 545001 ISIN: INE356Y01018 ISIN: INE356Y01018 Subject: Intimation under Regulation 6(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) Dear Sir/Madam, With reference to the above subject matter, this is to inform you that Ms. Deepshikha Singhal (ACS – 35992) was appointed as the Company Secretary & Compliance officer of Sahajanand Medical Technologies Limited (“the Company”) w.e.f. April 01, 2025, by the Board of Director at its meeting held on April 16, 2025. Further, please note that the Compliance Officer is an officer who is in whole-time employment of the Company, not more than one level below the Board of Directors, and is designated as a Key Managerial Personnel of the Company of the Company. The above intimation is also available on the website of the Company at www.smtpl.com and on the website of BSE and NSE. We request you to kindly take the same on record. Thanking you, For Sahajanand Medical Technologies Limited Bhargav Dhirajlal Kotadia Managing Director & Chief Executive Officer DIN: 06575042